Glenmede Small Cap Equity Adv holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Glenmede Small Cap Equity Portfolio Class Advisor GTCSX
- NAV / 1-Day Return $34.82 / +0.17 %
- Fund Size $938.9M
- Adjusted Expense Ratio 0.920%
- Net Expense Ratio 0.920%
- Fee Level: Distribution Below Average
- Share Class Type No Load
- Morningstar Category Small Blend
- Equity Style Box (Funds) Small Value
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.35%
- Turnover Ratio 27%
Morningstar’s Analysis GTCSX
Will GTCSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Neogen Corp | 2.04 | 18M | Healthcare |
Everforth Inc | 1.95 | 18M | Technology |
NeoGenomics Inc | 1.94 | 17M | Healthcare |
Haemonetics Corp | 1.94 | 17M | Healthcare |
CACI International Inc Class A | 1.93 | 17M | Technology |
Arcosa Inc | 1.92 | 17M | Industrials |
Marex Group Ltd | 1.72 | 15M | Financial Services |
Five9 Inc | 1.71 | 15M | Technology |
Cathay General Bancorp | 1.67 | 15M | Financial Services |
SM Energy Co | 1.62 | 15M | Energy |